determination of AB-PINACA and its metabolites in human urine at a cutoff
concentration of 5 ng/mL. The assay is intended for use in laboratories with
automated clinical chemistry analyzers.
AB-PINACA Assay
The ARK AB-PINACA Assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used in order to obtain a
confirmed positive analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) or Liquid Chromatography/tandem Mass Spectrometry (LC-MS/MS) is the
preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug test result, particularly when the preliminary
test result is positive.
KEY POINTS
Convenient, liquid-stable, ready-to-use homogeneous enzyme immunoassay
5 ng/mL cutoff
Excellent sensitivity and specificity for detection of AB-PINACA and its metabolites in human urine
Nonhazardous preservatives
Reagent on-board stability
Up to at least 60 days
Shelf Life of Reagents, Calibrators, and Controls
18 months from date of manufacturing
Safety
Nonhazardous preservatives
Contains sodium azide ≤ 0.09%
Results shown are typical and may vary among laboratory analyzers.